Cargando…

Low‐dose vemurafenib in hairy cell leukemia patients with active infection

Detalles Bibliográficos
Autores principales:	Bohn, Jan‐Paul, Pircher, Andreas, Wanner, David, Vill, David, Foeger, Bernhard, Wolf, Dominik, Steurer, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2019
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593695/ https://www.ncbi.nlm.nih.gov/pubmed/30916799 http://dx.doi.org/10.1002/ajh.25474

Ejemplares similares

The Biology of Classic Hairy Cell Leukemia
por: Bohn, Jan-Paul, et al.
Publicado: (2021)

Hairy Cell Leukemia Patients Have a Normal Life Expectancy—A 35-Year Single-Center Experience and Comparison with the General Population
por: Bohn, Jan-Paul, et al.
Publicado: (2022)

Targeting MEK in vemurafenib-resistant hairy cell leukemia
por: Caeser, Rebecca, et al.
Publicado: (2018)

Clonal dynamics in a composite chronic lymphocytic leukemia and hairy cell leukemia‐variant
por: Locher, Maurus, et al.
Publicado: (2020)

Long-term treatment of hairy cell leukemia with interferon-α: still a viable therapeutic option
por: Bohn, Jan-Paul, et al.
Publicado: (2016)

Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab Pasudotox
por: Robak, Tadeusz, et al.
Publicado: (2021)

Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah’s Witness patient
por: Schlaweck, Sebastian, et al.
Publicado: (2021)

Case report: A case of classic hairy cell leukemia with CNS involvement treated with vemurafenib
por: Johnson, Anna E., et al.
Publicado: (2023)

Hairy cell leukemia expresses programmed death-1
por: Kumar, Priyadarshini, et al.
Publicado: (2020)

Types of second primary cancers influence survival in chronic lymphocytic and hairy cell leukemia patients
por: Zheng, Guoqiao, et al.
Publicado: (2019)

Treatment of Classic Hairy Cell Leukemia: Targeting Minimal Residual Disease beyond Cladribine
por: Bohn, Jan-Paul, et al.
Publicado: (2022)

Single‐center study of outcomes of patients with hairy cell leukemia who contracted SARS‐CoV‐2
por: Annunzio, Kaitlin, et al.
Publicado: (2023)

Chronic lymphocytic leukemia at ASH 2017
por: Wanner, David, et al.
Publicado: (2018)

Long term follow-up of refractory/relapsed hairy cell leukaemia patients treated with low-dose vemurafenib between 2013 and 2022 at the Department of Internal Medicine and Oncology, Semmelweis University
por: Ferenczi, Kata, et al.
Publicado: (2023)

Hairy cell leukemia – immunotargets and therapies
por: Basheer, Faisal, et al.
Publicado: (2014)

Genomics of Hairy Cell Leukemia
por: Tiacci, Enrico, et al.
Publicado: (2017)

Hairy cell leukemia: short review, today's recommendations and outlook
por: Maevis, V, et al.
Publicado: (2014)

Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders
por: Maitre, Elsa, et al.
Publicado: (2022)

Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients
por: Maitre, Elsa, et al.
Publicado: (2022)

Hairy Cell Leukemia Masquerading as Pancytopenia in Pregnancy
por: Shackleton, Louisa, et al.
Publicado: (2019)

Allogeneic hematopoietic cell transplant for hairy cell leukemia: EBMT experience
por: Chihara, Dai, et al.
Publicado: (2022)

Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold?
por: Ferrara, Felicetto
Publicado: (2020)

BRAF Mutation in Hairy Cell Leukemia
por: Ahmadzadeh, Ahmad, et al.
Publicado: (2014)

Skeletal involvement of hairy cell leukemia
por: Durot, Eric, et al.
Publicado: (2018)

Time to Cure Hairy Cell Leukemia
por: Levy, Ilana, et al.
Publicado: (2017)

An Unusual Presentation of Hairy Cell Leukemia
por: Gajendra, Smeeta, et al.
Publicado: (2019)

Variant form of hairy cell leukemia
por: Wiber, Margaux, et al.
Publicado: (2019)

Skin changes in hairy cell leukemia
por: Robak, Ewa, et al.
Publicado: (2020)

Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders
por: Maitre, Elsa, et al.
Publicado: (2022)

Response to Vemurafenib in Metastatic Triple-Negative Breast Cancer Harbouring a BRAF V600E Mutation: A Case Report and Electronically Captured Patient-Reported Outcome
por: Pircher, Magdalena, et al.
Publicado: (2021)

Successful re-treatment of a relapsed V600E mutated HCL patient with low-dose vemurafenib
por: Bailleux, Caroline, et al.
Publicado: (2014)

Simultaneous Presentation of Hairy Cell Leukemia and Acute Lymphoblastic Leukemia
por: Li, Mingyong, et al.
Publicado: (2021)

Laparoscopic Splenectomy for Hairy Cell Leukemia in Pregnancy
por: Adeniji, Beni Adegoke, et al.
Publicado: (2010)

A Unique Hairy Cell Leukemia Variant
por: Jian, Charles, et al.
Publicado: (2016)

Development of Recombinant Immunotoxins for Hairy Cell Leukemia
por: Kreitman, Robert J., et al.
Publicado: (2020)

Disseminated Histoplasmosis with Concurrent Hairy Cell Leukemia
por: Khan, Abdul Moiz, et al.
Publicado: (2020)

Patients with relapsed/refractory hairy‐cell leukemia
por: Paillassa, Jérôme, et al.
Publicado: (2021)

Hairy Cell Leukemia: Where Are We in 2023?
por: Mendez-Hernandez, Andres, et al.
Publicado: (2023)

Hairy cell leukemia with isolated bone lesions
por: Cailly, Laura, et al.
Publicado: (2023)

Combined vemurafenib and fotemustine in patients with BRAF V600 melanoma progressing on vemurafenib
por: Queirolo, Paola, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2t2jkrh29p0bu712rrrpgrp1dn